万博互联网怎么样了 //www.j-zx.com/ Healthcare technology news, life science current events Fri, 21 Jul 2023 14:32:55 +0000 en-US hourly 1 https://wordpress.org/?v=6.0.5 //www.j-zx.com/uploads/2021/03/cropped-mblue-32x32.png 万博互联网怎么样了 //www.j-zx.com/ 32 32 40682243 医疗支出负担更高的医疗保险Households than Non-Medicare Households //www.j-zx.com/2023/07/healthcare-spending-burden-is-higher-for-medicare-households-than-non-medicare-households/ //www.j-zx.com/2023/07/healthcare-spending-burden-is-higher-for-medicare-households-than-non-medicare-households/#respond Marissa Plescia Thu, 20 Jul 2023 22:51:50 +0000 Consumer / Employer Daily Payers SYN Top Story healthcare spending KFF Medicare //www.j-zx.com/?p=642249

On average, Medicare households spent 15% of their total spending on health-related expenses in 2021, versus 7% for non-Medicare households, according to a new KFF report.

//www.j-zx.com/2023/07/healthcare-spending-burden-is-higher-for-medicare-households-than-non-medicare-households/feed/ 0 642249
How a ‘Costco Model’ for Health Care Supply Chain Presents a Best Bet for Value //www.j-zx.com/2023/07/how-a-costco-model-for-health-care-supply-chain-presents-a-best-bet-for-value/ //www.j-zx.com/2023/07/how-a-costco-model-for-health-care-supply-chain-presents-a-best-bet-for-value/#respond Dan Hurry Thu, 20 Jul 2023 21:15:09 +0000 Daily Devices & Diagnostics MedCity Influencers Top Story hospital supply chain supply chain supply chain management //www.j-zx.com/?p=639432

By reimagining health care supply chain as a centralized, high-value distribution and product selection and procurement model, hospitals and health systems can more effectively reach their goals for expense reduction while driving substantial improvements for patients and team members alike.

//www.j-zx.com/2023/07/how-a-costco-model-for-health-care-supply-chain-presents-a-best-bet-for-value/feed/ 0 639432
Peterson Center on Healthcare Launches $50M Institute To Assess Digital Health Solutions //www.j-zx.com/2023/07/health-technology-digital-payers-providers-employers/ //www.j-zx.com/2023/07/health-technology-digital-payers-providers-employers/#respond Marissa Plescia Thu, 20 Jul 2023 21:07:34 +0000 Daily Health Tech SYN Top Story 万博官方网站手机版 Peterson Center on Healthcare Peterson Health Technology Institute //www.j-zx.com/?p=642198

The Peterson Health Technology Institute will function as an “independent evaluator” of digital health solutions. It will analyze solutions’ clinical effectiveness, how they’re affecting healthcare costs, their ability to improve health equity, and their privacy and security capabilities. 

//www.j-zx.com/2023/07/health-technology-digital-payers-providers-employers/feed/ 0 642198
Why the Pandemic Was a Turning Point for Nurses Flexing Union Power //www.j-zx.com/2023/07/pandemic-nurse-labor-union-workforce-shortage/ //www.j-zx.com/2023/07/pandemic-nurse-labor-union-workforce-shortage/#respond Katie Adams Thu, 20 Jul 2023 20:45:33 +0000 Health Tech Hospitals Top Story contracts Kaiser Permanente Kaiser Permanente strike labor union McLaren Health Care nurse burnout nursing shortage strike //www.j-zx.com/?p=642108

race, racial groups,

Nurse unions and labor experts agree that the pandemic was a turning point that catalyzed nurses to fight for improved working conditions and overall better treatment from their employers. By negotiating new contracts with their employers, unions are working hard to both uphold patient safety and mitigate the nursing field’s debilitating workforce shortage.

//www.j-zx.com/2023/07/pandemic-nurse-labor-union-workforce-shortage/feed/ 0 642108
Covid is Still With Us. What Does That Mean for Your Brain? //www.j-zx.com/2023/07/covid-is-still-with-us-what-does-that-mean-for-your-brain/ //www.j-zx.com/2023/07/covid-is-still-with-us-what-does-that-mean-for-your-brain/#respond Elli Kaplan Thu, 20 Jul 2023 19:11:35 +0000 Consumer / Employer Daily MedCity Influencers Top Story alzheimer's disease biopharma nl dementia //www.j-zx.com/?p=639420 < p > < a href = " //www.j-zx.com/2023/07/covid-is-still-with-us-what-does-that-mean-for-your-brain/">

We may not fully understand the link between Covid-19 and Alzheimer’s, but we already have the scientific research and tools to address people’s fears, support their cognitive health journey, and reverse the increase of Alzheimer’s.

//www.j-zx.com/2023/07/covid-is-still-with-us-what-does-that-mean-for-your-brain/feed/ 0 639420
HCA, Tenet Saw Increased EBITDA in Q1 While Nonprofit Hospitals Continued to Struggle //www.j-zx.com/2023/07/hca-tenet-healthcare-hospital-expense-labor/ //www.j-zx.com/2023/07/hca-tenet-healthcare-hospital-expense-labor/#respond Katie Adams Thu, 20 Jul 2023 18:15:25 +0000 Daily Health Tech Hospitals Top Story HCA HCA Healthcare hospital finance labor costs Moody's Investor Service operating margins Tenet Healthcare Universal Health Services //www.j-zx.com/?p=642177

The nation’s two largest for-profit hospital chains — HCA and Tenet — increased their EBITDA as salary and benefit obligations became less burdensome in Q1. Unsurprisingly, the story for nonprofit hospitals is a bit different. For this class of health systems, the stress associated with labor costs is subsiding, but operating margins are having a difficult time bouncing back, according to a new Moody’s report.

//www.j-zx.com/2023/07/hca-tenet-healthcare-hospital-expense-labor/feed/ 0 642177
Sanofi Puts Up $125M to Partner on Oral Drug That Could Be Dupixent’s Successor //www.j-zx.com/2023/07/sanofi-puts-up-125m-to-partner-on-oral-drug-that-could-be-dupixents-successor/ //www.j-zx.com/2023/07/sanofi-puts-up-125m-to-partner-on-oral-drug-that-could-be-dupixents-successor/#respond Frank Vinluan Thu, 20 Jul 2023 17:13:17 +0000 BioPharma Daily Pharma Startups Top Story biopharma nl deals Dupixent inflammation Recludix Pharma San Diego Sanofi //www.j-zx.com/?p=642153

Sanofi is interested in Recludix Pharma’s approach to treating inflammation with an oral small molecule that targets a protein thought to be undruggable. If it works, the drug could have safety and dosing advantages over currently available biologic drugs, including blockbuster Sanofi drug Dupixent.

//www.j-zx.com/2023/07/sanofi-puts-up-125m-to-partner-on-oral-drug-that-could-be-dupixents-successor/feed/ 0 642153
Medicaid MCOs Denied 1 out of 8 Prior Authorization Requests in 2019 //www.j-zx.com/2023/07/medicaid-prior-authorization-denials-oig/ //www.j-zx.com/2023/07/medicaid-prior-authorization-denials-oig/#respond Marissa Plescia Wed, 19 Jul 2023 22:32:26 +0000 Consumer / Employer Daily Payers Top Story managed care organizations Medicaid Office of Inspector General prior authorization //www.j-zx.com/?p=642129

Medicaid managed care organizations deny prior authorization requests at high rates, according to a recent report by the Office of Inspector General. Of the 115 MCOs the OIG analyzed, 12 had prior authorization denial rates above 25%.

//www.j-zx.com/2023/07/medicaid-prior-authorization-denials-oig/feed/ 0 642129
Startup Launches Out of Redesign Health To Combat Loneliness Among Older Adults //www.j-zx.com/2023/07/seniors-older-adults-community-loneliness-startup/ //www.j-zx.com/2023/07/seniors-older-adults-community-loneliness-startup/#respond Marissa Plescia Wed, 19 Jul 2023 20:54:55 +0000 Consumer / Employer Health Tech SYN Top Story loneliness Peppermint Redesign Health senior care //www.j-zx.com/?p=642081

senior, loneliness, tablet

Peppermint is an “online clubhouse community” for adults aged 55 and older that allows them to connect with others through online clubs (like for traveling or gardening), workshops (like for nutrition or photography) and collaboration (where members can work together on activities like creating a recipe book). It aims to reduce loneliness by creating a sense of community and purpose for older adults, Peppermint’s CEO said.

//www.j-zx.com/2023/07/seniors-older-adults-community-loneliness-startup/feed/ 0 642081
Amarin Restructures, Charting Course That Braces for Generic Competition //www.j-zx.com/2023/07/amarin-restructures-charting-course-that-braces-for-generic-competition/ //www.j-zx.com/2023/07/amarin-restructures-charting-course-that-braces-for-generic-competition/#respond Frank Vinluan Wed, 19 Jul 2023 18:05:45 +0000 BioPharma Daily Pharma SYN Top Story Amarin biopharma nl Bridgewater cardiovascular disease generic drugs layoffs New Jersey Vascepa //www.j-zx.com/?p=642069 < p > < a href = " //www.j-zx.com/2023/07/amarin-restructures-charting-course-that-braces-for-generic-competition/">heart, doctor, cardiac

The restructuring of cardiovascular drugmaker Amarin means the layoff of about 30% of staff. Sales of Vascepa, the company’s only commercialized product, have suffered as generic versions gain traction in the market.

//www.j-zx.com/2023/07/amarin-restructures-charting-course-that-braces-for-generic-competition/feed/ 0 642069
Here’s Why Novartis Is Paying $500M to Acquire a Preclinical RNA Startup //www.j-zx.com/2023/07/heres-why-novartis-is-paying-500m-to-acquire-a-preclinical-rna-startup/ //www.j-zx.com/2023/07/heres-why-novartis-is-paying-500m-to-acquire-a-preclinical-rna-startup/#respond Frank Vinluan Wed, 19 Jul 2023 00:06:13 +0000 BioPharma Daily Pharma Top Story deals DTx Pharma muscle disorder drug Novartis rare disease San Diego Startups Switzerland //www.j-zx.com/?p=642030

Novartis’s acquisition of DTx Pharma brings a lead program for a rare disease with no FDA-approved therapies. But the deal could also help the pharma giant bring new RNA therapies to new places in the body, a top Novartis executive explained.

//www.j-zx.com/2023/07/heres-why-novartis-is-paying-500m-to-acquire-a-preclinical-rna-startup/feed/ 0 642030
Fewer Physicians Are Practice Owners Than Ever & Medicare Rates Are to Blame, AMA Says //www.j-zx.com/2023/07/ama-physician-employment-healthcare-medicare/ //www.j-zx.com/2023/07/ama-physician-employment-healthcare-medicare/#respond Katie Adams Wed, 19 Jul 2023 00:03:20 +0000 Daily Health IT Top Story AMA American Medical Association Medicare physician practice private practice //www.j-zx.com/?p=642042

Over the past decade, a significant percentage of the country’s physicians have shifted from working in private practices (defined as those owned wholly by physicians) to working in bigger, health system-owned practices. The ability to negotiate higher payment rates with insurers when working at a larger practice is a crucial factor causing this trend, according to a new AMA analysis.

//www.j-zx.com/2023/07/ama-physician-employment-healthcare-medicare/feed/ 0 642042
Right Now: ‘Insourcing’ Dialysis Can Deliver Big Cost Savings, Better Outcomes //www.j-zx.com/2023/07/right-now-insourcing-dialysis-can-deliver-big-cost-savings-better-outcomes/ //www.j-zx.com/2023/07/right-now-insourcing-dialysis-can-deliver-big-cost-savings-better-outcomes/#respond Michael Aragon Tue, 18 Jul 2023 22:43:53 +0000 Daily Devices & Diagnostics Hospitals MedCity Influencers News Top Story hemodialysis //www.j-zx.com/?p=638928

When facilities operate their own acute dialysis operations and no longer enlist third parties to provide treatment, they save hundreds of dollars per session. Insourcing also enables hospitals to keep trained dialysis staff on hand full-time to actively ensure quality kidney care to their patients.

//www.j-zx.com/2023/07/right-now-insourcing-dialysis-can-deliver-big-cost-savings-better-outcomes/feed/ 0 638928
Survey: 85% of Employees Don’t Use Their Mental Health Benefits //www.j-zx.com/2023/07/employees-employers-mental-health-benefits-telehealth/ //www.j-zx.com/2023/07/employees-employers-mental-health-benefits-telehealth/#respond Marissa Plescia Tue, 18 Jul 2023 22:08:30 +0000 Consumer / Employer Daily Health Tech SYN Top Story AmWell employee health benefits Mental Health //www.j-zx.com/?p=642021

More than half of employees said they don’t have mental health benefits in their benefit package or aren’t sure if they do, according to a new survey. About two-thirds of respondents said they would use a digital mental health benefit if it was offered to them.

//www.j-zx.com/2023/07/employees-employers-mental-health-benefits-telehealth/feed/ 0 642021
Herself Health Secures $26M To Bring Primary Care to Women Ages 65+ //www.j-zx.com/2023/07/women-health-senior-care-primary-tech/ //www.j-zx.com/2023/07/women-health-senior-care-primary-tech/#respond Marissa Plescia Tue, 18 Jul 2023 19:48:01 +0000 Daily Health Tech Payers Top Story Herself Health primary care senior care Women's Health //www.j-zx.com/?p=642009

Herself Health’s $26 million Series A funding round was led by Michael Cline, founding managing partner of Accretive, and included participation from Juxtapose. It comes six months after Herself Health raised $7 million in seed funding. In total, the company has raised $33 million.

//www.j-zx.com/2023/07/women-health-senior-care-primary-tech/feed/ 0 642009
64% of Clinicians Feel Physically Unsafe at Work, Report Says //www.j-zx.com/2023/07/clinician-healthcare-workplace-safety/ //www.j-zx.com/2023/07/clinician-healthcare-workplace-safety/#respond Katie Adams Tue, 18 Jul 2023 18:49:12 +0000 Daily Health Tech Hospitals Top Story clinicians Doximity ED violence hospital violence violence workplace violence //www.j-zx.com/?p=642000

A new survey revealed that 64% of clinicians feel physically unsafe at work. The perceived risk of violence was especially high among women, clinicians under age 40, emergency department physicians and employees who work with patients struggling with addiction or other mental health conditions.

//www.j-zx.com/2023/07/clinician-healthcare-workplace-safety/feed/ 0 642000
Pfizer, Flagship Team Up in $100M R&D Pact: 10 New Drugs for Unmet Needs //www.j-zx.com/2023/07/pfizer-flagship-pioneering-drug-discovery-research/ //www.j-zx.com/2023/07/pfizer-flagship-pioneering-drug-discovery-research/#respond Frank Vinluan Tue, 18 Jul 2023 14:45:35 +0000 BioPharma Pharma Top Story biopharma nl Cambridge deals drug discovery Flagship Pioneering Massachusetts Pfizer //www.j-zx.com/?p=641967

Pfizer and Flagship Pioneering are partnering in a drug research alliance leveraging the capabilities of the more than 40 biotech startups in the venture capital firm’s portfolio. The new partners aim to develop drugs for unmet needs, including those in broad patient populations.

//www.j-zx.com/2023/07/pfizer-flagship-pioneering-drug-discovery-research/feed/ 0 641967
An AI-Enabled Approach to Improve Access to Physical Therapy for Self-Insured Employers [Sponsored] //www.j-zx.com/2023/07/an-ai-enabled-approach-to-improve-access-to-physical-therapy-for-self-insured-employers/ //www.j-zx.com/2023/07/an-ai-enabled-approach-to-improve-access-to-physical-therapy-for-self-insured-employers/#respond Stephanie Baum Tue, 18 Jul 2023 11:30:17 +0000 Daily Health Services Health Tech News Sponsored Post Top Story Mike Sokol MSK physical therapy Presented by Quantum Health Sponsored Content Sword Health Vijay Yamadala //www.j-zx.com/?p=641004

Quantum Health has bolstered its collaboration with Sword Health by integrating MSK services to members to track home exercise, avoid unnecessary surgery and support treatment of pelvic conditions.

//www.j-zx.com/2023/07/an-ai-enabled-approach-to-improve-access-to-physical-therapy-for-self-insured-employers/feed/ 0 641004
Advice Given by ChatGPT Vs. Human Providers Is Nearly Indistinguishable, NYU Study Says //www.j-zx.com/2023/07/chatgpt-llm-healthcare-ai-nyu/ //www.j-zx.com/2023/07/chatgpt-llm-healthcare-ai-nyu/#respond Katie Adams Mon, 17 Jul 2023 22:59:17 +0000 Daily Health Tech Top Story AI in healthcare ChatGPT EHR LLMs NYU Langone patient messaging //www.j-zx.com/?p=641952

NYU researchers conducted a study this year in which nearly 400 people were asked to identify whether responses to patient questions were produced by human providers or ChatGPT. Participants had a limited ability to tell the source of the responses apart, so the study authors concluded that the use of LLMs like ChatGPT could be an effective way to streamline healthcare providers’ communication with patients.

//www.j-zx.com/2023/07/chatgpt-llm-healthcare-ai-nyu/feed/ 0 641952
Prominence Health Plan Taps Strive Health for Kidney Care //www.j-zx.com/2023/07/chronic-kidney-care-home-telehealth-partnership/ //www.j-zx.com/2023/07/chronic-kidney-care-home-telehealth-partnership/#respond Marissa Plescia Mon, 17 Jul 2023 22:31:12 +0000 Daily Health Tech Payers Top Story kidney care Prominence Health Plan Strive Health //www.j-zx.com/?p=641937 < p > < a href = " //www.j-zx.com/2023/07/chronic-kidney-care-home-telehealth-partnership/">

Prominence Health Medicare Advantage enrollees will have 24/7 access to Strive Health’s specialized care team through a new partnership. Strive Health is also teaming up with Sierra Nevada Specialty Care, a local nephrology clinic in Nevada.

//www.j-zx.com/2023/07/chronic-kidney-care-home-telehealth-partnership/feed/ 0 641937
FDA Approval of RSV Drug Gives Infants and Toddlers Long-Lasting Protection //www.j-zx.com/2023/07/fda-approval-rsv-drug-infants-toddlers-astrazeneca-sanofi/ //www.j-zx.com/2023/07/fda-approval-rsv-drug-infants-toddlers-astrazeneca-sanofi/#respond Frank Vinluan Mon, 17 Jul 2023 22:28:57 +0000 BioPharma Daily Legal Pharma Top Story AstraZeneca biopharma nl Clinical Trials FDA respiratory syncytial virus Sanofi //www.j-zx.com/?p=641928

AstraZeneca and Sanofi drug Beyfortus is now FDA approved for preventing respiratory problems from RSV infection in infants and toddlers. Antibody engineering enables the drug to last longer in the body, providing protective effects for potentially the entire RSV season.

//www.j-zx.com/2023/07/fda-approval-rsv-drug-infants-toddlers-astrazeneca-sanofi/feed/ 0 641928
The Kraft Heinz Lawsuit Against Aetna Is the ‘Tip of the Iceberg’ //www.j-zx.com/2023/07/kraft-heinz-aetna-lawsuit-fiduciary-claims-data-employers/ //www.j-zx.com/2023/07/kraft-heinz-aetna-lawsuit-fiduciary-claims-data-employers/#respond Marissa Plescia Mon, 17 Jul 2023 21:25:26 +0000 Consumer / Employer Legal Top Story Aetna claims data fiduciary responsibility Kraft Heinz lawsuit //www.j-zx.com/?p=641856

Kraft Heinz recently sued Aetna, claiming that the insurer is not providing all of Kraft Heinz’s medical claims data. More lawsuits of this sort are likely to come, experts warned.

//www.j-zx.com/2023/07/kraft-heinz-aetna-lawsuit-fiduciary-claims-data-employers/feed/ 0 641856
What Misconceptions Does the Healthcare Industry Still Have About Home-Based Care? //www.j-zx.com/2023/07/home-healthcare-startups/ //www.j-zx.com/2023/07/home-healthcare-startups/#respond Katie Adams Mon, 17 Jul 2023 19:56:28 +0000 Daily Health Tech Startups Top Story digital health investment home healthcare Laguna Health Tomorrow Health //www.j-zx.com/?p=641883 < p > < a href = " //www.j-zx.com/2023/07/home-healthcare-startups/">home care

The at-home care field holds significant market potential. As the subsector continues to grow, some leaders of home healthcare startups are challenging misconceptions that some other industry stakeholders may still have, including the misbelief that at-home care is only for senior citizens and that this care model lacks scalability.

//www.j-zx.com/2023/07/home-healthcare-startups/feed/ 0 641883
Eli Lilly Strengthens the Case for Going Early in Alzheimer’s Treatment //www.j-zx.com/2023/07/eli-lilly-early-alzheimers-disease-drug-donanemab/ //www.j-zx.com/2023/07/eli-lilly-early-alzheimers-disease-drug-donanemab/#respond Frank Vinluan 星期一,2023年7月17日19:35:28 + 0000 BioPharma Daily Pharma Top Story alzheimer's disease biopharma nl Clinical Trials donanemab Eli Lilly FDA Indianapolis //www.j-zx.com/?p=641877

Alzheimer’s disease patients in the earliest stages of their disease benefited the most from Eli Lilly drug donanemab, which is expected to receive an FDA decision by the end of 2023. Full results from the drug’s pivotal study were presented during the during the Alzheimer’s Association International Conference.

//www.j-zx.com/2023/07/eli-lilly-early-alzheimers-disease-drug-donanemab/feed/ 0 641877
Ticking the Talons of Healthcare Transparency //www.j-zx.com/2023/07/ticking-the-talons-of-healthcare-transparency/ //www.j-zx.com/2023/07/ticking-the-talons-of-healthcare-transparency/#respond Peter J. Pitts Mon, 17 Jul 2023 10:27:18 +0000 Consumer / Employer Daily Legal MedCity Influencers Payers Top Story price transparency //www.j-zx.com/?p=641736

price transparency

As of January 1, employer-sponsored Group Health Plans and Health Insurance Issuers must make make the prices of 500 medical services available via an Internet-based tool. The Transparency in Coverage final rule gets even tougher on January 1, 2024, when the prices of all medical services must be made available via an Internet-based tool.

//www.j-zx.com/2023/07/ticking-the-talons-of-healthcare-transparency/feed/ 0 641736
Hospital M&A Activity Caught Up to Pre-Pandemic Levels in Q2 //www.j-zx.com/2023/07/hospital-merger-acquisition-healthcare-kaufman-hall/ //www.j-zx.com/2023/07/hospital-merger-acquisition-healthcare-kaufman-hall/#respond Katie Adams Sun, 16 Jul 2023 15:11:55 +0000 Health Tech Hospitals Top Story BJC Healthcare Geisinger healthcare mergers Kaiser Permanente Kaufman Hall mega-mergers Mergers and Acquisitions ThedaCare Transactions //www.j-zx.com/?p=641760 < p > < a href = " //www.j-zx.com/2023/07/hospital-merger-acquisition-healthcare-kaufman-hall/">

M&A activity among hospitals and health systems increased in Q2 of 2023 — there were 20 deals in Q2 compared to 15 deals in Q1, according to a new report. This surge brought Q2’s M&A activity levels in line with those observed before the pandemic. Q2’s 20 deal marks the highest number of announced transactions for hospitals and health systems since Q1 of 2020.

//www.j-zx.com/2023/07/hospital-merger-acquisition-healthcare-kaufman-hall/feed/ 0 641760
Report: 10 Prescription Drugs Took Up 22% of Medicare Part D Spending in 2021 //www.j-zx.com/2023/07/prescription-drugs-spending-cost-medicare/ //www.j-zx.com/2023/07/prescription-drugs-spending-cost-medicare/#respond Marissa Plescia Sun, 16 Jul 2023 13:30:22 +0000 Consumer / Employer Daily Payers SYN Top Story CMS KFF Medicare Part D prescription drug costs //www.j-zx.com/?p=641766

KFF found that the 10 top-selling Part D drugs represented $47.7 billion of the $215.7 billion total gross Medicare Part D drug spending in 2021. Eliquis, a blood thinner by Bristol Myers Squibb, accounted for the most spending out of these 10 drugs at $12.6 billion. 

//www.j-zx.com/2023/07/prescription-drugs-spending-cost-medicare/feed/ 0 641766
Startup Tenpoint Lands $70M to Bring Vision-Restoring Cell Therapy to the Eye //www.j-zx.com/2023/07/regenerative-medicine-cell-therapy-startup-degenerative-eye-disorder/ //www.j-zx.com/2023/07/regenerative-medicine-cell-therapy-startup-degenerative-eye-disorder/#respond Frank Vinluan Sun, 16 Jul 2023 12:32:01 +0000 BioPharma Daily Pharma Startups Top Story cell therapy Eddy Anglade eye disease London regenerative medicine Tenpoint Therapeutics //www.j-zx.com/?p=641781 < p > < a href = " //www.j-zx.com/2023/07/regenerative-medicine-cell-therapy-startup-degenerative-eye-disorder/">

Tenpoint Therapeutics’ name refers to the time it takes for an image to hit the retina and be processed by the brain. The regenerative medicine startup is developing cell therapies it hopes restore that vision capability for patients with degenerative eye disorders.

//www.j-zx.com/2023/07/regenerative-medicine-cell-therapy-startup-degenerative-eye-disorder/feed/ 0 641781
It’s Time to Make Effective Alternatives a Bigger Part of the CPAP Recall Story //www.j-zx.com/2023/07/its-time-to-make-effective-alternatives-a-bigger-part-of-the-cpap-recall-story/ //www.j-zx.com/2023/07/its-time-to-make-effective-alternatives-a-bigger-part-of-the-cpap-recall-story/#respond Dr. Edward T. Sall Fri, 14 Jul 2023 19:58:24 +0000 Daily Devices & Diagnostics MedCity Influencers Top Story CPAP Medical device recalls //www.j-zx.com/?p=638907

For those unfamiliar with the CPAP recall situation in question, imagine if one-third of all cars on the road were suddenly recalled for potentially life-threatening issues. Now imagine that in the aforementioned hypothetical automobile recall, the media dedicated its energy almost entirely to reporting on the worsening problem without making viewers aware of potential solutions.

//www.j-zx.com/2023/07/its-time-to-make-effective-alternatives-a-bigger-part-of-the-cpap-recall-story/feed/ 0 638907
‘This Is Almost Biblical in Its Impact’: Providers Push Back Against CMS’ New Proposed Rules //www.j-zx.com/2023/07/cms-healthcare-inflation-reimbursement/ //www.j-zx.com/2023/07/cms-healthcare-inflation-reimbursement/#respond Katie Adams Fri, 14 Jul 2023 19:16:01 +0000 Hospitals Legal Top Story American Hospital Association American Medical Association CMS Medicaid Medicare outpatient care physician fee schedule physician payment //www.j-zx.com/?p=641679

handcuffs, law, lawyer, charge, fraud, legal

CMS recently revealed its proposals to raise reimbursement rates for hospital outpatient departments and cut payments for physicians. Next year, the agency is planning to decrease physicians’ pay by 1.25% and increase outpatient payment rates by 2.8%. Provider groups are unhappy with the news — AMA President Dr. Jesse Ehrenfeld said the new physician fee schedule will be “almost biblical in its impact.”

//www.j-zx.com/2023/07/cms-healthcare-inflation-reimbursement/feed/ 0 641679
Baidu